CAS 51116-01-9: Guanosine, 8-bromo-, cyclic 3′,5′-(hydrogen phosphate), sodium salt (1:1)

Formel: C₁₀H₁₁BrN₅O₇P·Na

InChl: InChI=1S/C10H11BrN5O7P.Na/c11-9-13-3-6(14-10(12)15-7(3)18)16(9)8-4(17)5-2(22-8)1-21-24(19,20)23-5;/h2,4-5,8,17H,1H2,(H,19,20)(H3,12,14,15,18);/t2-,4-,5-,8-;/m1./s1

InChI Key: InChIKey=FJAOOACZDYDVJT-YEOHUATISA-N

SMILES: [Na].O=C1N=C(N)NC2=C1N=C(Br)N2C3OC4COP(=O)(O)OC4C3O

Synonyme:

• 2-amino-8-bromo-9-[(4aR,6R,7R,7aS)-2,7-dihydroxy-2-oxidotetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphinin-6-yl]-3,9-dihydro-6H-purin-6-one
• 4H-Furo[3,2-d]-1,3,2-dioxaphosphorin, guanosine deriv.
• 8-Bromo-cGMP monosodium salt
• 8-Bromo-cGMP, Sodium Salt
• 8-Bromoguanosine 3:5-Cyclic*Monophosphate Sodiu
• 8-Bromoguanosine cyclic 3′,5′-monophosphate sodium salt
• 8-Bromoguanosine-3,5-cyclomonophosphate sodium salt
• Guanosine, 8-bromo-, cyclic 3′,5′-(hydrogen phosphate), monosodium salt
• Guanosine, 8-bromo-, cyclic 3′,5′-(hydrogen phosphate), sodium salt (1:1)
• sodium (4aR,6R,7R,7aS)-6-(2-amino-8-bromo-6-oxo-3,6-dihydro-9H-purin-9-yl)-7-hydroxytetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphinin-2-olate 2-oxide

8-Bromoguanosine 3'',5''-cyclic monophosphate sodium salt

CAS: 51116-01-9

• Formel: C₁₀H₁₀BrN₅NaO₇P
• Reinheit: ≥ 99.0% (HPLC)
• Farbe und Form: White to off-white powder
• Molekulargewicht: 446.08

8-Bromoguanosine 3',5'-cyclic monophosphate sodium salt

CAS: 51116-01-9

Activator of cGMP-dependent protein kinases

• Formel: C₁₀H₁₀BrN₅NaO₇P
• Reinheit: Min. 95%
• Farbe und Form: Powder
• Molekulargewicht: 446.08 g/mol

8-bromo-cGMP sodium salt

CAS: 51116-01-9

• Formel: C₁₀H₁₀BrN₅O₇P·Na
• Farbe und Form: Neat
• Molekulargewicht: 446.083

8-Bromo-cGMP sodium

CAS: 51116-01-9

8-Bromo-cGMP sodium: PKG activator, eases pain, dilates vessels, reduces Ca2+ currents & insulin release.

• Formel: C₁₀H₁₀BrN₅NaO₇P
• Reinheit: 99.91%
• Farbe und Form: Solid
• Molekulargewicht: 446.09